These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36429970)

  • 1. "Everything…Fell Apart Once COVID-19 Hit"-Leveraging the COVID-19 Response to Strengthen Public Health Activities toward Ending the HIV Epidemic: A Qualitative Study.
    Devlin SA; Garcia M; Fujimoto K; Hallmark C; McNeese M; Schneider J; McNulty MC
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pathogen, same disparities: why COVID-19 and HIV remain prevalent in U.S. communities of colour and implications for ending the HIV epidemic.
    Millett GA
    J Int AIDS Soc; 2020 Nov; 23(11):e25639. PubMed ID: 33222424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. America's HIV Epidemic Analysis Dashboard: Protocol for a Data Resource to Support Ending the HIV Epidemic in the United States.
    Sullivan PS; Woodyatt CR; Kouzouian O; Parrish KJ; Taussig J; Conlan C; Phillips H
    JMIR Public Health Surveill; 2022 Feb; 8(2):e33522. PubMed ID: 35142639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of COVID-19 on the HIV continuum of care: challenges, innovations, and opportunities.
    Kim JYH; Barth SK; Monroe AK; Ahsan S; Kovacic J; Senn S; Castel AD
    Expert Rev Anti Infect Ther; 2023; 21(8):831-846. PubMed ID: 37470436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. African American Clergy Recommendations to Enhance the Federal Plan to End the HIV Epidemic: A Qualitative Study.
    Arnold T; Haynes T; Foster P; Parker S; Monger M; Malyuta Y; Cain O; Coats CS; Murphy M; Thomas G; Sockwell L; Klasko-Foster L; Galipeau D; Dobbs TE; Smith M; Mena L; Nunn A
    AIDS Behav; 2022 Jan; 26(Suppl 1):100-111. PubMed ID: 34417672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Testing Before and During the COVID-19 Pandemic - United States, 2019-2020.
    DiNenno EA; Delaney KP; Pitasi MA; MacGowan R; Miles G; Dailey A; Courtenay-Quirk C; Byrd K; Thomas D; Brooks JT; Daskalakis D; Collins N
    MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(25):820-824. PubMed ID: 35737573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review.
    Patel P; Kerzner M; Reed JB; Sullivan PS; El-Sadr WM
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37479. PubMed ID: 35486813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing Racism's Role in the US HIV Epidemic: Qualitative Findings From Three Ending the HIV Epidemic Prevention Projects.
    Harrison SE; Muessig K; Poteat T; Koester K; Vecchio A; Paton M; Miller SJ; Pereira N; Harris O; Myers J; Campbell C; Hightow-Weidman L
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S46-S55. PubMed ID: 35703755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.
    Sullivan PS; Mouhanna F; Mera R; Pembleton E; Castel AD; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Siegler AJ
    Ann Epidemiol; 2020 Apr; 44():16-30. PubMed ID: 32088073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community and Provider Perspectives on Molecular HIV Surveillance and Cluster Detection and Response for HIV Prevention: Qualitative Findings From King County, Washington.
    Shook AG; Buskin SE; Golden M; Dombrowski JC; Herbeck J; Lechtenberg RJ; Kerani R
    J Assoc Nurses AIDS Care; 2022 May-Jun 01; 33(3):270-282. PubMed ID: 35500058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ending the HIV Epidemic: Contributions Resulting From Syphilis Partner Services.
    DiOrio D; Collins D; Hanley S
    Sex Transm Dis; 2020 Aug; 47(8):511-515. PubMed ID: 32520880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of COVID-19 Response on the HIV Epidemic in Men Who Have Sex With Men in San Francisco County: The Importance of Rapid Return to Normalcy.
    Liang C; Suen SC; Nguyen A; Moucheraud C; Hsu L; Holloway IW; Charlebois ED; Steward WT
    J Acquir Immune Defic Syndr; 2023 Apr; 92(5):370-377. PubMed ID: 36728397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease surveillance infrastructure and the economisation of public health.
    Decoteau CL; Garrett CL
    Sociol Health Illn; 2022 Sep; 44(8):1251-1269. PubMed ID: 35932244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Can Progress Toward Ending the Human Immunodeficiency Virus Epidemic in the United States Be Monitored?
    Mitchell KM; Maheu-Giroux M; Dimitrov D; Moore M; Hughes JP; Donnell D; Beyrer C; El-Sadr WM; Cohen MS; Boily MC
    Clin Infect Dis; 2022 Aug; 75(1):163-169. PubMed ID: 34849635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Changes in Racial/Ethnic Disparities of HIV Diagnosis Rates Under the "Ending the HIV Epidemic: A Plan for America" Initiative.
    McCree DH; Chesson H; Bradley ELP; Williams A; Gant Z; Geter A
    Public Health Rep; 2020; 135(5):685-690. PubMed ID: 32762633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the US National HIV Strategy and Ending the HIV Epidemic Initiative.
    McGee KS
    Nurs Clin North Am; 2024 Jun; 59(2):297-308. PubMed ID: 38670696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ending the HIV Epidemic: Identifying Barriers and Facilitators to Implement Molecular HIV Surveillance to Develop Real-Time Cluster Detection and Response Interventions for Local Communities.
    Garcia M; Devlin S; Kerman J; Fujimoto K; Hirschhorn LR; Phillips G; Schneider J; McNulty MC
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing HIV Prevention Efforts to Achieve EHE Incidence Targets.
    Jacobson EU; Hicks KA; Carrico J; Purcell DW; Green TA; Mermin JH; Farnham PG
    J Acquir Immune Defic Syndr; 2022 Apr; 89(4):374-380. PubMed ID: 35202046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
    Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
    J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ending the HIV Epidemic in Black America: Qualitative Insights Following COVID-19.
    Lewis TJ; Herring RP; Chinnock RE; Nelson A
    J Racial Ethn Health Disparities; 2024 Feb; ():. PubMed ID: 38386258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.